AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 20 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,928,000 | -17.6% | 390,390 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $3,553,000 | -17.7% | 390,390 | -36.5% | 0.01% | 0.0% |
| Q4 2021 | $4,318,000 | -69.7% | 615,095 | -50.8% | 0.01% | -72.2% |
| Q3 2021 | $14,242,000 | -8.8% | 1,249,328 | +28.1% | 0.02% | -5.3% |
| Q2 2021 | $15,617,000 | +316.0% | 975,454 | +364.3% | 0.02% | +280.0% |
| Q1 2021 | $3,754,000 | +32.3% | 210,089 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $2,838,000 | +5.3% | 210,089 | -8.2% | 0.00% | 0.0% |
| Q3 2020 | $2,694,000 | – | 228,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 157,390,000 | $141,877,000 | 3.17% |
| Birch Grove Capital LP | 8,000,000 | $7,200,000 | 2.94% |
| PFM Health Sciences, LP | 48,150,000 | $43,919,000 | 1.64% |
| SILVERBACK ASSET MANAGEMENT LLC | 8,505,000 | $7,665,000 | 1.04% |
| DAFNA Capital Management LLC | 1,500,000 | $1,345,000 | 0.35% |
| DeepCurrents Investment Group LLC | 8,696,000 | $7,756,000 | 0.24% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11,092,000 | $10,005,000 | 0.23% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,235,000 | $8,358,000 | 0.13% |
| Verition Fund Management LLC | 2,441,000 | $2,227,000 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $5,473,000 | 0.02% |